Page last updated: 2024-08-23

du-21220 and Erythema

du-21220 has been researched along with Erythema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayabe, T; Fuse, Y; Hayashi, T; Higaki, H; Higaki, Y; Kido, K; Kikuchi, A; Matsumoto, S; Sasamori, Y; Shiba, M; Shinozuka, N; Taguchi, A; Umezawa, K1
Kasamatsu, H; Okamoto, Y; Yamada, T1

Other Studies

2 other study(ies) available for du-21220 and Erythema

ArticleYear
Erythematous and bullous rash strongly indicating toxic epidermal necrolysis associated with the use of intravenous ritodrine hydrochloride.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:3

    Topics: Adrenergic beta-Agonists; Adult; Blister; Cesarean Section; Erythema; Female; Glucocorticoids; Humans; Prednisolone; Pregnancy; Ritodrine; Stevens-Johnson Syndrome; Treatment Outcome

2010
Ritodrine-induced skin rash.
    Archives of gynecology and obstetrics, 2001, Volume: 264, Issue:4

    Topics: Adrenergic beta-Agonists; Adult; Erythema; Female; Humans; Obstetric Labor, Premature; Pregnancy; Ritodrine; Tocolytic Agents

2001